Dignitana convenes Training Academy bringing distributors to Lund Headquarters
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Dignitana convenes Training Academy bringing distributors to Lund Headquarters

{newsItem.title}

Scalp cooling innovator Dignitana AB has brought together MedTech experts from five regions around the globe for the first ever Dignitana Distributor Training Academy held in Lund this week.

Distributors participating in the event include: OncoMedical (Switzerland and Liechtenstein), Science International Corp (Hong Kong and Macao), Konica Minolta (Japan), Celeritas Trading & Consulting (Mexico) and Colvin & Cia (Chile).

“In addition to expanding the product and clinical expertise of our partners, this event allows for a collaborative exchange of MedTech knowledge and experience from markets around the world,” said Catarina Löwenadler, Dignitana CEO.  “With a superior product and a common goal of serving more patients, we can deepen our relationships and continue to expand our strategic initiatives into key markets.”

The event allowed participants to focus on specific functions and knowledge needed for successful sales and implementation of DigniCap Delta in their region, including clinical training for patient-focused roles, technical service certification, as well as business and product insights to deepen their understanding scalp cooling therapy and  related business strategies. Some participants also shared their local outcomes that have demonstrated the superior efficacy of DigniCap Delta over other scalp cooling systems.

The FDA-cleared DigniCap Scalp Cooling System minimizes hair loss from chemotherapy for cancer patients with solid tumors such as breast, ovarian and prostate cancer.  It is available in its primary US market and in cancer centers around the globe. Recognized internationally as a standard of care and quality of life advancement for cancer patients, scalp cooling is a treatment recommendation in the clinical practice guidelines published by National Comprehensive Cancer Network® (NCCN), European Society for Medical Oncology (ESMO), and Cancer Australia.

Bifogade filer

Nyheter om Dignitana

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Dignitana

Senaste nytt